Skip to content

Acute Infantile Spinal Muscular Atrophy C4024911

Published: July 22, 2026Updated: August 25, 2026

A genetic muscle-wasting disease affecting infants, causing severe weakness and often breathing problems. Often fatal in early childhood.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized hypotonia

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Progressive muscle weakness

!

Respiratory failure

Feeding difficulties

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease-Modifying Pharmacotherapy

FDA-approved SMN-enhancing therapies that target the underlying genetic cause of spinal muscular atrophy. These treatments aim to increase production of functional survival motor neuron protein.

medication
2

Image-guided procedure with follow-up care

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Respiratory Function Surveillance

Regular monitoring of respiratory function including pulmonary function tests, overnight oximetry, and assessment for sleep-disordered breathing. Early intervention for respiratory infections and provision of airway clearance techniques.

monitoring

Additional treatment options

Motor Function Physical Therapy

Specialized physical therapy focused on maintaining muscle strength, preventing contractures, promoting motor development, and maximizing functional independence through age-appropriate activities and exercises.

physical_therapy

Nutritional Support and Feeding Management

Assessment and management of nutritional status including evaluation of swallowing function, caloric needs, and supplementation as needed. May include modified textures, feeding schedules, or enteral nutrition support.

dietary

Psychosocial Support Services

Comprehensive psychosocial support addressing emotional adjustment, school integration, social skills development, and family functioning. Includes counseling, support groups, and connection to community resources.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Infantile Spinal Muscular Atrophy C4024911?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018.

guideline2018
2

Kolb SJ, Kissel JT. Spinal muscular atrophy: A timely review. Arch Neurol. 2011.

review2011
3

Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017.

clinical_trial2017
4

Sverdrup FM, Højfeldt N, Vissing J. Treatment outcomes in spinal muscular atrophy: A systematic review and meta-analysis. J Neurol. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Acute Infantile Spinal Muscular Atrophy C4024911. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy